Saloshnee is an Assistant Director responsible for transaction execution as well as supporting the origination of majority and minority investment opportunities. She has been involved in our investments in Rosemont Pharmaceuticals, Pharmaspectra, Atcore, SteriPack and Proteros. 

Prior to joining Inflexion, Saloshnee spent six years at Gleacher Shacklock, where she gained corporate finance experience working on a range of deals including the sale of the NEC Group, the acquisition of Phase Eight, and the IPO of Nobina.

Outside the office, Saloshnee enjoys following rugby and cricket, travelling and dining out.

She has a BSc in Economics and Geography from University College London.